Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Ophthalmology. 2013 Apr 9;120(7):1313–1323. doi: 10.1016/j.ophtha.2013.01.027

Figure 5.

Figure 5

Kaplan-Meier analysis of recurrences in patients treated for lacrimal gland adenoid cystic carcinoma (ACC). Compares the cumulative Kaplan-Meier proportions of patients without recurrence treated with intraarterial cytoreductive chemotherapy (IACC) as designed, IACC with protocol deviation, and historical control conventionally treated patients at Bascom Palmer Eye Institute (BPEI).